Michael S. Wyand

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Philip W. Kantoff, Thomas Schuetz, Brent A. Blumenstein et al. · Journal of Clinical Oncology · 2010 · 973 citations

Medicine, Immunology, Oncology +17

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

Harriet L. Robinson, David C. Montefiori, R. Paul Johnson et al. · Nature Medicine · 1999 · 380 citations

Life Sciences, Immunology, Infectious Diseases +16

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus

Michael S. Wyand, Kelledy Manson, M Garcia-Moll et al. · Journal of Virology · 1996 · 320 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Vaccine protection against simian immunodeficiency virus infection.

Ronald C. Desrosiers, Michael S. Wyand, Toshiaki Kodama et al. · Proceedings of the National Academy of Sciences · 1989 · 315 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Simian immunodeficiency virus DNA vaccine trial in macaques

Shan Lu, James Arthos, David C. Montefiori et al. · Journal of Virology · 1996 · 241 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17